ACOMS+ 및 학술지 리포지터리 설명회

  • 한국과학기술정보연구원(KISTI) 서울분원 대회의실(별관 3층)
  • 2024년 07월 03일(수) 13:30
 

  • P-ISSN2233-4203
  • E-ISSN2093-8950
  • ESCI, SCOPUS, KCI

논문 상세

Home > 논문 상세
  • P-ISSN 2233-4203
  • E-ISSN 2093-8950

Diagnostic Evaluation of Enzyme Activity Related to Steroid Metabolism by Mass Spectrometry-Based Steroid Profiling

Mass Spectrometry Letters / Mass Spectrometry Letters, (P)2233-4203; (E)2093-8950
2014, v.5 no.2, pp.35-41
https://doi.org/10.5478/MSL.2014.5.2.35
Man Ho Cho (Korea Institute of Science and Technology)
Bong Chul Chung (Korea Institute of Science and Technology)
  • 다운로드 수
  • 조회수

Abstract

Gas chromatography-mass spectrometry (GC-MS) methods have been used extensively in clinical steroid analyses. Evaluating the metabolic ratios of precursors to products by accurate quantification of individual steroid levels in biologicalsamples can reveal the activities of enzymes associated with steroid metabolism. This review article discusses the impact of GCMS-based steroid profiling on our understanding of the biochemical role of steroids and their metabolic enzymes in hormonedependentdiseases, such as congenital adrenal hyperplasia (CAH), cortisol-mediated hypertension, apparent mineralocorticoidexcess (AME), male-pattern baldness, and breast and thyroid cancers. Steroid profiling is a comprehensive analytical techniquethat can be applied whenever the highest specificity is required and may be a reasonable initial diagnostic approach.

keywords
steroid, metabolite profiling, biomarker, clinical diagnosis, steroidogenesis


참고문헌

1

Caulfield, M. P.. (2002). . J. Clin. Endocrinol. Metabol, 87, 3682-.

2

Minutti, C. Z.. (2004). . J. Clin. Endocrinol. Metabol, 89, 3687-.

3

White, P. C.. (1997). . Endo. Rev, 18, 135-.

4

Choi, M. H.. (2002). . Clin. Chim. Acta, 320, 95-.

5

Randall, V. A.. (1992). . J. Invest. Dermatol, 98, 86S-.

6

Choi, M. H.. (2001). . J. Invest. Dermatol, 116, 57-.

7

Baglietto, L.. (2010). . Cancer Epidemiol. Biomarkers Prev, 19, 492-.

8

Choi, M. H.. (2011). . J. BMC Cancer, 11, 342-.

9

Liu, W.. (2013). . J. Lipid Res, 54, 244-.

10

Son, H. H.. (2014). . J. Lipid Res, 55, 155-.

11

Moon, J. Y.. (2014). . J. Steroid Biochem. Mol. Biol, 141, 52-.

12

Kölsch, H.. (2004). . Neurosci. Lett, 368, 303-.

13

Shobob, L. A.. (2005). . Lancet Neurol, 4, 841-.

14

Karasinska, J. M.. (2011). . Nat. Rev. Neurol, 7, 561-.

15

Moon, J. Y.. (2009). . J. Am. Soc. Mass Spectrom, 20, 1626-.

16

Sharpe, L. J.. (2013). . J. Biol. Chem, 288, 18707-.

17

Xu, X.. (2007). . Nat. Protocol, 2, 1350-.

18

Cho, H. J.. (2009). . Anal. Chim. Acta, 632, 101-.

19

Riepe, F. G.. (2007). . Rev. Endocr. Metab. Disord, 8, 349-.

20

Wudy, S. A.. (1995). . Pediatr. Res, 38, 76-.

21

Wudy, S. A.. (2000). . Horm. Res, 53, 68-.

22

Lai, C. C.. (2002). . J. Clin. Lab Anal, 16, 20-.

23

Wong, T.. (1992). . Clin. Chem, 38, 1830-.

24

Kaddurah-Daouk, R.. (2008). . Annu. Rev. Pharmacol. Toxicol, 653, 48-.

25

Holst, J. P.. (2007). . Steroids, 72, 71-.

26

Sahin, Y.. (1997). . Eur. J. Endocrinol, 137, 670-.

27

Rauh, M.. (2009). . Mol. Cell. Endocrinol, 301, 272-.

28

Sun Ju Kim. (2011). Screening Analysis of 10 Adrenal Steroids by Matrix-Assisted Laser Desorption Ionization-Tandem Mass Spectrometry. Mass Spectrometry Letters, 2(3), 69-72.

29

Raff, H.. (1987). . Am. J. Physiol, 252, R635-.

30

Stewart, P. M.. (1996). . Lancet, 347, 88-.

31

Palermo, M.. (1996). . Clin. Endocrinol, 45, 605-.

32

Mantero, F.. (1996). . Steroids, 61, 193-.

33

Ferrari, P.. (2000). . Kideny Int, 57, 1374-.

34

Walker, B. R.. (1997). . J. Clin. Endocrinol. Metabol, 82, 4015-.

35

Sawaya, M.. (1991). . Ann. N. Y. Acad. Sci, 642, 376-.

36

Sinclair, R.. (1998). . Br. Med. J, 317, 865-.

37

Randall, V. A.. (1994). . Clin. Endocrinol, 40, 439-.

38

Sawaya, M. E.. (1997). . J. Invest. Dermatol, 109, 296-.

39

Hibberts, N. A.. (1998). . J. Endocrinol, 156, 59-.

40

Phillipou, G. Kirk. (1981). . J. Clin. Exp. Dermatol, 6, 53-.

41

Choi, M. H.. (1999). . Analyst, 124, 1297-.

42

Jung, H. J.. (2011). . Rapid Commun. Mass Spectrom, 25, 1184-.

43

Choi, M. H.. (2014). . J. Invest. Dermatol, 20, 1626-.

44

Ross, R. K.. (1992). . Lancet, 339, 887-.

45

Pettaway, C. A.. (1999). . J. Natl. Med. Assoc, 91, 653-.

46

Hoffman, R.. (2000). . Eur. J. Dermatol, 10, 410-.

47

Eliassen, A. H.. (2008). . Cancer Epidemiol. Biomarkers Prev, 17, 2029-.

48

Arslan, A. A.. (2009). . Cancer Epidemiol. Biomarkers Prev, 18, 2273-.

49

Liehr, J. G.. (1996). (3294-). Proc. Natl. Acad. Sci. USA.

50

Castagnetta, L. A. M.. (2002). . Clin. Cancer Res, 8, 3146-.

51

Moon, J. Y.. (2013). . BMC Clin. Pathol, 13, 25-.

52

Choi, M. H.. (2011). . J. BMC Cancer, 11, 342-.

투고일Submission Date
2014-05-27
수정일Revised Date
2014-06-05
게재확정일Accepted Date
2014-06-05
상단으로 이동

Mass Spectrometry Letters